Association between interleukin-6 and lower urinary tract symptoms of benign prostatic hyperplasia

被引:4
|
作者
Zhang, Qiang [1 ]
Jiang, Kang [1 ]
Huo, Ri-cha [1 ]
Zhang, Jun-qiang [1 ]
Yang, Zhi-gang [1 ]
机构
[1] Baotou Cent Hosp, Dept Urol, Botou, Inner Mongolia, Peoples R China
来源
REVISTA INTERNACIONAL DE ANDROLOGIA | 2023年 / 21卷 / 02期
关键词
Interleukin-6 (IL-6); Cytokine; Inflammation; Lower urinary tract symptoms; Benign prostate hyperplasia; ASYMPTOMATIC INFLAMMATORY PROSTATITIS; C-REACTIVE PROTEIN; PROGRESSION; EXPRESSION; CYTOKINE; IL-6; HEALTH; RISK; MEN;
D O I
10.1016/j.androl.2021.10.002
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Objective: To evaluate the association between IL-6 in prostatic tissue/blood sample and BPH-LUTS, so as to preliminarily discover an indicator of inflammation that could show the severity of LUTS. Patients and methods: The prostatic tissues and blood samples were collected from 56 patients who underwent transurethral plasmakinetic resection of the prostate (TUPKRP). The associa-tion between IL-6 detected on prostatic tissues/blood sample and LUTS parameters, including international prostate symptom score (IPSS), peak flow rate (Qmax) and urodynamic parame-ters were analyzed with SPSS version 18.0, and p-value <0.05 was chosen as the criterion for statistical significance. Results: The TPSA and prostate volume (PV) were found to be higher in the inflammation group (p = 0.021, 0.036). There was a positive association between prostate tissue inflammation and LUTS ([IPSS, storage symptoms score (SSS), voiding symptoms score (VSS), p < 0.05], [Qmax, p = 0.025], [obstruction, p = 0.027] and [AUR, p = 0.018]). The level of serum IL-6 was significantly higher in inflammatory group (p = 0.008). However, no differences were observed in different degrees of inflammation (p = 0.393). The level of IL-6 in prostatic tissue significantly increased with the degree of inflammation (p < 0.001), and the intensity of IL-6 expression was statistically correlative with the degree of inflammation (p < 0.001). The IL-6 expression in prostatic tissue was statistically relevant with IPSS (p = 0.018) and SSS (p = 0.012). Conclusion: IL-6 expression in prostatic tissue is associated with storage IPSS, suggesting chronic inflammation might contribute to storage LUTS. (c) 2022 Asociacion Espanola de Andrologi ' a, Medicina Sexual y Reproductiva. Published by Else-vier Espana, S.L.U. All rights reserved.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Prevention or Retention?
    Schneider, Tim
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (11) : 696 - 701
  • [42] Benign Prostatic Hyperplasia and the Medication Management of Associated Lower Urinary Tract Symptoms
    Knezevich, Emily L.
    Knezevich, Jon T.
    Spangler, Mikayla L.
    US PHARMACIST, 2011, 36 (06)
  • [43] SILDENAFIL FOR TREATMENT OF LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA
    Ragheb, Ahmed M.
    Arafa, Mahmoud M.
    Moussa, Ayman S.
    Massoud, Amr M.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E99 - E99
  • [44] Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia
    Rohrbough, C. R.
    Colgan, Bridget
    Gasser, Ollie
    AMERICAN FAMILY PHYSICIAN, 2024, 109 (01) : 83 - 84
  • [45] Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
    Hwang, Eu Chang
    Gandhi, Shreyas
    Jung, Jae Hung
    Imamura, Mari
    Kim, Myung Ha
    Pang, Ran
    Dahm, Philipp
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (10):
  • [46] Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
    Jung, Jae Hung
    Kim, Jiye
    MacDonald, Roderick
    Reddy, Balaji
    Kim, Myung Ha
    Dahm, Philipp
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11):
  • [47] IMPACT OF TREATMENTS FOR LOWER URINARY TRACT SYMPTOMS/BENIGN PROSTATIC HYPERPLASIA ON EJACULATION
    Drasa, K.
    Dani, E.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 251 - 251
  • [48] Metabolic syndrome in the etiology of benign prostatic hyperplasia/lower urinary tract symptoms
    Turker, Polat
    Yazici, Cenk M.
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (04): : 227 - 231
  • [49] Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
    Gonzalez, Ricardo R.
    Kaplan, Steven A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (04) : 609 - 617
  • [50] Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia
    Michel, MC
    Mehlburger, L
    Schumacher, H
    Bressel, HU
    Goepel, M
    JOURNAL OF UROLOGY, 2000, 163 (06): : 1725 - 1729